Segments of Business and Geographic Areas (Tables)

9 Months Ended

Oct. 02, 2011

Segments of Business and Geographic Areas [Abstract]

Sales by segment of business

SALES BY SEGMENT OF BUSINESS

	Fiscal Third Quarters Ended
	October 2,		October 3,		Percent
(Dollars in Millions)	2011		2010		Change
Consumer
United States	$	1,219	$	1,277		(4.5	)%
International		2,521		2,290		10.1
Total		3,740		3,567		4.9
Pharmaceutical
United States		2,869		3,054		(6.1	)
International		3,113		2,441		27.5
Total		5,982		5,495		8.9
Medical Devices & Diagnostics
United States		2,780		2,800		(0.7	)
International		3,503		3,120		12.3
Total		6,283		5,920		6.1
Worldwide
United States		6,868		7,131		(3.7	)
International		9,137		7,851		16.4
Total	$	16,005	$	14,982		6.8	%

	Fiscal Nine Months Ended
	October 2,		October 3,		Percent
(Dollars in Millions)	2011		2010		Change
Consumer
United States	$	3,903	$	4,300		(9.2	)%
International		7,312		6,680		9.5
Total		11,215		10,980		2.1
Pharmaceutical
United States		9,499		9,370		1.4
International		8,775		7,316		19.9
Total		18,274		16,686		9.5
Medical Devices & Diagnostics
United States		8,521		8,551		(0.4	)
International		10,765		9,726		10.7
Total		19,286		18,277		5.5
Worldwide
United States		21,923		22,221		(1.3	)
International		26,852		23,722		13.2
Total	$	48,775	$	45,943		6.2	%

Operating profit by segment of business

OPERATING PROFIT BY SEGMENT OF BUSINESS

	Fiscal Third Quarters Ended
	October 2,			October 3,			Percent
(Dollars in Millions)	2011			2010			Change
Consumer	$	644		$	501			28.5	%
Pharmaceutical		2,078			1,858			11.8
Medical Devices & Diagnostics		1,927			2,002			(3.7	)
Segments operating profit		4,649			4,361			6.6
Expense not allocated to segments (3)		(538	)		(142	)
Worldwide income before taxes	$	4,111		$	4,219			(2.6	)%

	Fiscal Nine Months Ended
	October 2,			October 3,			Percent
(Dollars in Millions)	2011			2010			Change
Consumer	$	1,766		$	1,955			(9.7	)%
Pharmaceutical (1)		6,001			5,661			6.0
Medical Devices & Diagnostics (2)		5,146			7,580			(32.1	)
Segments operating profit		12,913			15,196			(15.0	)
Expense not allocated to segments (3)		(870	)		(477	)
Worldwide income before taxes	$	12,043		$	14,719			(18.2	)%

(1)	Includes litigation expense of $540 million and a gain related to the Company’s earlier investment in Crucell recorded in the fiscal nine months of 2011. The fiscal nine months of 2010 includes net litigation expense of $202 million.
(2)	Includes restructuring expense of $676 million recorded in the fiscal nine months of 2011. Includes litigation expense and additional DePuy ASR™ Hip recall costs of $223 million recorded in the fiscal nine months of 2011. Includes net litigation income of $1,542 million recorded in the fiscal nine months of 2010.

(3) Amounts not allocated to segments include interest income/(expense), non-controlling interests and general corporate income/(expense).

Sales by geographic area

SALES BY GEOGRAPHIC AREA

	Fiscal Third Quarters Ended
	October 2,		October 3,		Percent
(Dollars in Millions)	2011		2010		Change
United States	$	6,868	$	7,131		(3.7	)%
Europe		4,124		3,629		13.6
Western Hemisphere, excluding U.S.		1,751		1,424		23.0
Asia-Pacific, Africa		3,262		2,798		16.6
Total	$	16,005	$	14,982		6.8	%

	Fiscal Nine Months Ended
	October 2,		October 3,		Percent
(Dollars in Millions)	2011		2010		Change
United States	$	21,923	$	22,221		(1.3	)%
Europe		12,850		11,563		11.1
Western Hemisphere, excluding U.S.		4,730		4,079		16.0
Asia-Pacific, Africa		9,272		8,080		14.8
Total	$	48,775	$	45,943		6.2	%